Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers.

Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. Abstract Text:

Toshio Iwata,Takeshi Kamegai,Yoshie Yamauchi-Sato,Akiko Ogawa,Michio Kasai,Toshiaki Aoyama,Kazuo Kondo,Toshio Iwata,Takeshi Kamegai,Yoshie Yamauchi-Sato,Akiko Ogawa,Michio Kasai,Toshiaki Aoyama,Kazuo Kondo,

A study was conducted to investigate the short-term safety of dietary conjugated linoleic acid (CLA) in overweight Japanese male volunteers. The study design was a randomized, double-blind placebo-controlled trial including 60 healthy overweight volunteers (body mass index (BMI), 25 approximately 35 kg/m(2)). The subjects were randomly assigned to three groups: 5.4 g CLA-triacylglycerol (3.4 g as CLA), 10.8 g CLA-triacylglycerol (6.8 g as CLA) and placebo (10.8 g safflower oil) daily for 12 weeks. The CLA-triaclyglycerol contained 9c,11t- and 10t,12c-isomers at an equal proportion. The safety was evaluated by analyses of blood parameters and by clinical examinations at the baseline, and at 6 and 12 weeks, including vital signs and adverse effects. All subjects completed the study. The occurrence of adverse events tended to be higher in the CLA groups than in the placebo group, but all of the adverse events were mild to moderate, within normal ranges, and temporary. Serum aspartate aminotransferase (AST) activity did not differ significantly between the groups at 12 weeks, but in the high CLA group it was slightly increased from the baseline. Serum alanine aminotransferase (ALT) activity was higher in the high CLA group than in the placebo group after 12 weeks and was higher than at the baseline in both CLA groups. However, statistical analysis of the population of apparently healthy volunteers who had normal blood parameters at the baseline revealed that AST and ALT levels did not differ significantly among the 3 groups at 12 weeks. Moreover, no clinically significant changes in vital signs were observed in any of the groups. These results indicate that CLA at a dose of 3.4 g/day is a safe dietary level in healthy Japanese populations in terms of the parameters examined.

Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. Publishing Authors By Initials

T Iwata,T Kamegai,Y Yamauchi-Sato,A Ogawa,M Kasai,T Aoyama,K Kondo,T Iwata,T Kamegai,Y Yamauchi-Sato,A Ogawa,M Kasai,T Aoyama,K Kondo,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. Journal Published:

PUBLICATION TYPE: Randomized Controlled Trial

Journal: Journal of oleo science

VOLUME: 56

Page Numbers: 517-25

Journal Abbreviation:

ISSN: 1347-3352

DAY: 27

MONTH: 09

YEAR: 2007

Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101175339

Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers.

AFFILIATION: Research Laboratory, The Nisshin OilliO Group, Ltd., Tokyo, Japan. t-iwata@nisshin-oillio.com

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Oleo Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Safety of dietary conjugated linoleic acid CLA in a 12-weeks trial in healthy overweight Japanese male volunteers Related Publications

• A fatal case of pontine hemorrhage related to methamphetamine abuse.
• A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
• Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment.
• Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy.
• Changes in blood flow in a conduit artery and superficial vein of the upper arm during passive heating in humans.
• Clinical and bacteriological evaluation of the efficacy of piperacillin in children with pneumonia.
• Dietary medium- and long-chain triacylglycerols accelerate diet-induced thermogenesis in humans.
• Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
• Effects of dietary administration of plant-derived anthocyanin-rich colors to spontaneously hypertensive rats.
• Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway.
• Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
• Further studies on membrane transport with time delay.
• Identification of Alu-mediated, large deletion-spanning introns 19-26 in PHKA2 in a patient with X-linked liver glycogenosis (hepatic phosphorylase kinase deficiency).
• Immunopotentiators and the protection they give against carbon tetrachloride hepatotoxicity.
• Involvement of polycomb-group genes in establishing HoxD temporal colinearity.
• Kinetic and expression analyses of seven novel mutations in mitochondrial acetoacetyl-CoA thiolase (T2): identification of a Km mutant and an analysis of the mutational sites in the structure.
• Laparoscopic live donor nephrectomy in patients surgically treated for morbid obesity.
• Membrane potential and Donnan potential.
• Outcome of radical surgery for stage IV gallbladder carcinoma.
• Pigment pattern in jaguar/obelix zebrafish is caused by a Kir7.1 mutation: implications for the regulation of melanosome movement.
• Refractory osteomyelitis caused by bacille Calmette-Guérin vaccination: a case report.
• Relationship among the surface potential, Donnan potential and charge density of ion-penetrable membranes.
• Roles of mTOR and STAT3 in autophagy induced by telomere 3' overhang-specific DNA oligonucleotides.
• Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers.
• Sarcomatous hepatocellular carcinoma without previous anticancer therapy.
• Severe brainstem compression by an unruptured giant vertebral aneurysm--an autopsy case.
• Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
• Spindle cell-type undifferentiated carcinoma of the common bile duct of the hepatic hilus: report of a case.
• Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells.
• Transcranial sonography of the substantia nigra in patients with Parkinson's disease.